Cargando…

Meningioma causing gabapentin-responsive secondary SUNCT syndrome

Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) is one of the rarest and most serious headache disorders. Cases of symptomatic SUNCT syndromes are reported, which demonstrate that brain imaging is very important for diagnosis. In this study, we describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutschenko, Anna, Liebetanz, David
Formato: Texto
Lenguaje:English
Publicado: Springer Milan 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917557/
https://www.ncbi.nlm.nih.gov/pubmed/20428918
http://dx.doi.org/10.1007/s10194-010-0216-1
_version_ 1782185080362369024
author Kutschenko, Anna
Liebetanz, David
author_facet Kutschenko, Anna
Liebetanz, David
author_sort Kutschenko, Anna
collection PubMed
description Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) is one of the rarest and most serious headache disorders. Cases of symptomatic SUNCT syndromes are reported, which demonstrate that brain imaging is very important for diagnosis. In this study, we describe the first case of secondary SUNCT syndrome caused by a meningioma. So far, a clearly effective therapy for SUNCT syndrome has not been known. In this case, however, SUNCT was completely responsive to gabapentin. This underlines that this drug is worthy of being considered as a potential therapeutic option in the treatment of SUNCT syndrome.
format Text
id pubmed-2917557
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-29175572010-08-20 Meningioma causing gabapentin-responsive secondary SUNCT syndrome Kutschenko, Anna Liebetanz, David J Headache Pain Brief Report Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) is one of the rarest and most serious headache disorders. Cases of symptomatic SUNCT syndromes are reported, which demonstrate that brain imaging is very important for diagnosis. In this study, we describe the first case of secondary SUNCT syndrome caused by a meningioma. So far, a clearly effective therapy for SUNCT syndrome has not been known. In this case, however, SUNCT was completely responsive to gabapentin. This underlines that this drug is worthy of being considered as a potential therapeutic option in the treatment of SUNCT syndrome. Springer Milan 2010-04-29 /pmc/articles/PMC2917557/ /pubmed/20428918 http://dx.doi.org/10.1007/s10194-010-0216-1 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Brief Report
Kutschenko, Anna
Liebetanz, David
Meningioma causing gabapentin-responsive secondary SUNCT syndrome
title Meningioma causing gabapentin-responsive secondary SUNCT syndrome
title_full Meningioma causing gabapentin-responsive secondary SUNCT syndrome
title_fullStr Meningioma causing gabapentin-responsive secondary SUNCT syndrome
title_full_unstemmed Meningioma causing gabapentin-responsive secondary SUNCT syndrome
title_short Meningioma causing gabapentin-responsive secondary SUNCT syndrome
title_sort meningioma causing gabapentin-responsive secondary sunct syndrome
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917557/
https://www.ncbi.nlm.nih.gov/pubmed/20428918
http://dx.doi.org/10.1007/s10194-010-0216-1
work_keys_str_mv AT kutschenkoanna meningiomacausinggabapentinresponsivesecondarysunctsyndrome
AT liebetanzdavid meningiomacausinggabapentinresponsivesecondarysunctsyndrome